Skip to content

SYRESPYRE THERAPEUTICS INC

CUSIP 00773J202 · common stock

2 tracked investors held SPYRE THERAPEUTICS INC (SYRE) at the end of Q3 2026, worth $313.3M in total. The largest holder was Perceptive Advisors, with 5.1% of its portfolio. Chuck Royce sold out of its position this quarter.

Holders · Q3 2026
2
New holders
0
Value held
$313.3M
Quarter-end price (est.)
$89.03

Investors holding SYRE · Q3 2026

InvestorWeightSharesValueChange
Perceptive Advisors
Perceptive Advisors LLC
5.09%3,280,943$292.1MREDUCE-24.0%
Adar1 Capital Management
ADAR1 Capital Management, LLC
0.90%237,567$21.2MREDUCE-16.3%

Sold out this quarter

InvestorPrior weightPrior sharesPrior valueChange
Chuck Royce0.04%51,789$4.6MEXIT

History

QuarterHoldersNewSold outValue heldQuarter-end price (est.)
Q3 2026201$313.3M$89.03
Q2 2026312$413.3M$88.78
Q1 2026400$340.1M$50.44
Q4 2025400$187.5M$32.76